Bone quality: The determinants of bone strength and fragility

Sports Medicine

Volumn 44, Issue 1, 2014, Pages 37-53

  Fonseca, Hélder ^a   Moreira Gonçalves, Daniel ^a   Coriolano, Hans Joachim Appell ^b   Duarte, José Alberto ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HYDROXYAPATITE;

BONE; BONE DENSITY; BONE MATRIX; BONE MINERALIZATION; CHEMISTRY; HISTOLOGY; HUMAN; MECHANICS; OSTEOCYTE; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

BONE AND BONES; BONE DENSITY; BONE MATRIX; CALCIFICATION, PHYSIOLOGIC; COLLAGEN; HUMANS; HYDROXYAPATITES; MECHANICAL PHENOMENA; OSTEOCYTES; OSTEOPOROSIS;

EID: 84893159728     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.1007/s40279-013-0100-7     Document Type: Review

References (284)

1. NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785-95.
2. Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34(1):195-202.
3. Cranney A, Jamal SA, Tsang JF, et al. Low bone mineral density and fracture burden in postmenopausal women. CMAJ. 2007;177(6):575-80.
4. Pasco JA, Seeman E, Henry MJ, et al. The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int. 2006;17(9):1404-9.
5. Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003;18(11):1947-54.
6. Wainwright SA, Marshall LM, Ensrud KE, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005;90(5):2787-93.
7. Keaveny TM, Kopperdahl DL, Melton LJ 3rd, et al. Age-dependence of femoral strength in white women and men. J Bone Miner Res. 2010;25(5):994-1001.
8. Cummings SR, Karpf DB, Harris F, et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 2002;112(4):281-9.
9. Chen P, Miller PD, Delmas PD, et al. Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis. J Bone Miner Res. 2006;21(11):1785-90.
10. Watts NB, Cooper C, Lindsay R, et al. Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. J Clin Densitom. 2004;7(3):255-61.
11. Plotkin LI, Bellido T. Bisphosphonate-induced, hemichannel-mediated, anti-apoptosis through the Src/ERK pathway: a gap junction-independent action of connexin43. Cell Commun Adhes. 2001;8(4-6):377-82.
12. Plotkin LI, Aguirre JI, Kousteni S, et al. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation. J Biol Chem. 2005;280(8):7317-25.
13. Riggs BL, Hodgson SF, O'Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med. 1990;322(12):802-9.
14. Meunier PJ, Sebert JL, Reginster JY, et al. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Osteoporos Int. 1998;8(1):4-12.
15. Engelke K, Adams JE, Armbrecht G, et al. Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom. 2008;11(1):123-62.
16. Engelke K, Libanati C, Liu Y, et al. Quantitative computed tomography (QCT) of the forearm using general purpose spiral whole-body CT scanners: accuracy, precision and comparison with dual-energy X-ray absorptiometry (DXA). Bone. 2009;45(1):110-8.
17. Khoo BC, Brown K, Cann C, et al. Comparison of QCT-derived and DXA-derived areal bone mineral density and T scores. Osteoporos Int. 2009;20(9):1539-45.
18. Dall'Ara E, Pahr D, Varga P, et al. QCT-based finite element models predict human vertebral strength in vitro significantly better than simulated DEXA. Osteoporos Int. 2012;23(2):563-72.
19. Bergot C, Laval-Jeantet AM, Hutchinson K, et al. A comparison of spinal quantitative computed tomography with dual energy X-ray absorptiometry in European women with vertebral and nonvertebral fractures. Calcif Tissue Int. 2001;68(2):74-82.
20. Lang TF, Keyak JH, Heitz MW, et al. Volumetric quantitative computed tomography of the proximal femur: precision and relation to bone strength. Bone. 1997;21(1):101-8.
21. Bousson V, Le Bras A, Roqueplan F, et al. Volumetric quantitative computed tomography of the proximal femur: relationships linking geometric and densitometric variables to bone strength. Role for compact bone. Osteoporos Int. 2006;17(6):855-64.
22. Cody DD, Gross GJ, Hou FJ, et al. Femoral strength is better predicted by finite element models than QCT and DXA. J Biomech. 1999;32(10):1013-20.
23. Grampp S, Genant HK, Mathur A, et al. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res. 1997;12(5):697-711.
24. Chilibeck PD, Sale DG, Webber CE. Exercise and bone mineral density. Sports Med. 1995;19(2):103-22.
25. Suominen H. Bone mineral density and long term exercise. An overview of cross-sectional athlete studies. Sports Med. 1993;16(5):316-30.
26. Heinonen A, Oja P, Kannus P, et al. Bone mineral density in female athletes representing sports with different loading characteristics of the skeleton. Bone. 1995;17(3):197-203.
27. Heinonen A, Oja P, Kannus P, et al. Bone mineral density of female athletes in different sports. Bone Miner. 1993;23(1):1-14.
28. Wittich A, Mautalen CA, Oliveri MB, et al. Professional football (soccer) players have a markedly greater skeletal mineral content, density and size than age- and BMI-matched controls. Calcif Tissue Int. 1998;63(2):112-7.
29. Colletti LA, Edwards J, Gordon L, et al. The effects of muscle-building exercise on bone mineral density of the radius, spine, and hip in young men. Calcif Tissue Int. 1989;45(1):12-4.
30. Heinonen A, Sievanen H, Kyrolainen H, et al. Mineral mass, size, and estimated mechanical strength of triple jumpers' lower limb. Bone. 2001;29(3):279-85.
31. Morris FL, Naughton GA, Gibbs JL, et al. Prospective ten-month exercise intervention in premenarcheal girls: positive effects on bone and lean mass. J Bone Miner Res. 1997;12(9):1453-62.
32. Williams JA, Wagner J, Wasnich R, et al. The effect of long-distance running upon appendicular bone mineral content. Med Sci Sports Exerc. 1984;16(3):223-7.
33. MacKelvie KJ, Petit MA, Khan KM, et al. Bone mass and structure are enhanced following a 2-year randomized controlled trial of exercise in prepubertal boys. Bone. 2004;34(4):755-64.
34. Bradney M, Pearce G, Naughton G, et al. Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Miner Res. 1998;13(12):1814-21.
35. Saville PD, Whyte MP. Muscle and bone hypertrophy. Positive effect of running exercise in the rat. Clin Orthop Relat Res. 1969;65:81-8.
36. Forwood MR, Burr DB. Physical activity and bone mass: exercises in futility? Bone Miner. 1993;21(2):89-112.
37. Jarvinen TL, Kannus P, Sievanen H, et al. Randomized controlled study of effects of sudden impact loading on rat femur. J Bone Miner Res. 1998;13(9):1475-82.
38. McCarthy RN, Jeffcott LB. Effects of treadmill exercise on cortical bone in the third metacarpus of young horses. Res Vet Sci. 1992;52(1):28-37.
39. Nilsson M, Ohlsson C, Oden A, et al. Increased physical activity is associated with enhanced development of peak bone mass in men: a five-year longitudinal study. J Bone Miner Res. 2012;27(5):1206-14.
40. Erlandson M, Kontulainen S, Chilibeck P, et al. Higher premenarcheal bone mass in elite gymnasts is maintained into young adulthood after long-term retirement from sport: a 14-year follow-up. J Bone Miner Res. 2011;27(1):104-10.
41. Meyer U, Romann M, Zahner L, et al. Effect of a general school-based physical activity intervention on bone mineral content and density: a cluster-randomized controlled trial. Bone. 2011;48(4):792-7.
42. Gunter KB, Almstedt HC, Janz KF. Physical activity in childhood may be the key to optimizing lifespan skeletal health. Exerc Sport Sci Rev. 2012;40(1):13-21.
43. Berard A, Bravo G, Gauthier P. Meta-analysis of the effectiveness of physical activity for the prevention of bone loss in postmenopausal women. Osteoporos Int. 1997;7(4):331-7.
44. Kelley G. Aerobic exercise and lumbar spine bone mineral density in postmenopausal women: a meta-analysis. J Am Geriatr Soc. 1998;46(2):143-52.
45. Kelley GA. Aerobic exercise and bone density at the hip in postmenopausal women: a meta-analysis. Prev Med. 1998;27(6):798-807.
46. Wallace BA, Cumming RG. Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int. 2000;67(1):10-8.
47. Palombaro KM. Effects of walking-only interventions on bone mineral density at various skeletal sites: a meta-analysis. J Geriatr Phys Ther. 2005;28(3):102-7.
48. Kelley GA, Kelley KS. Exercise and bone mineral density at the femoral neck in postmenopausal women: a meta-analysis of controlled clinical trials with individual patient data. Am J Obstet Gynecol. 2006;194(3):760-7.
49. Martyn-St James M, Carroll S. Meta-analysis of walking for preservation of bone mineral density in postmenopausal women. Bone. 2008;43(3):521-31.
50. Robbins J, Aragaki AK, Kooperberg C, et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA. 2007;298(20):2389-98.
51. Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA. 2002;288(18):2300-6.
52. Moayyeri A. The association between physical activity and osteoporotic fractures: a review of the evidence and implications for future research. Ann Epidemiol. 2008;18(11):827-35.
53. Muraki S, Akune T, Oka H, et al. Physical performance, bone and joint diseases, and incidence of falls in Japanese men and women: a longitudinal cohort study. Osteoporos Int. 2013;24(2):459-66.
54. Peeters GM, van Schoor NM, Pluijm SM, et al. Is there a U-shaped association between physical activity and falling in older persons? Osteoporos Int. 2010;21(7):1189-95.
55. Huang TH, Chang FL, Lin SC, et al. Endurance treadmill running training benefits the biomaterial quality of bone in growing male Wistar rats. J Bone Miner Metab. 2008;26(4):350-7.
56. Lespessailles E, Jaffre C, Beaupied H, et al. Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats? Calcif Tissue Int. 2009;85(2):146-57.
57. Adami S, Gatti D, Braga V, et al. Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women. J Bone Miner Res. 1999;14(1):120-4.
58. Burr DB. The contribution of the organic matrix to bone's material properties. Bone. 2002;31(1):8-11.
59. Skedros JG, Dayton MR, Sybrowsky CL, et al. The influence of collagen fiber orientation and other histocompositional characteristics on the mechanical properties of equine cortical bone. J Exp Biol. 2006;209(Pt 15):3025-42.
60. Bolotin HH, Sievanen H, Grashuis JL. Patient-specific DXA bone mineral density inaccuracies: quantitative effects of nonuniform extraosseous fat distributions. J Bone Miner Res. 2003;18(6):1020-7.
61. Bolotin HH. A new perspective on the causal influence of soft tissue composition on DXA-measured in vivo bone mineral density. J Bone Miner Res. 1998;13(11):1739-46.
62. Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone. 1993;14(4):595-608.
63. Nalla RK, Kinney JH, Ritchie RO. Mechanistic fracture criteria for the failure of human cortical bone. Nat Mater. 2003;2(3):164-8.
64. Chappard D, Basle MF, Legrand E, et al. New laboratory tools in the assessment of bone quality. Osteoporos Int. 2011;22(8):2225-40.
65. Donnelly E. Methods for assessing bone quality: a review. Clin Orthop Relat Res. 2011;469(8):2128-38.
66. McCreadie BR, Goulet RW, Feldkamp LA, et al. Hierarchical structure of bone and micro-computed tomography. Adv Exp Med Biol. 2001;496:67-83.
67. Martin RM, Correa PH. Bone quality and osteoporosis therapy. Arquivos brasileiros de endocrinologia e metabologia. 2010;54(2):186-99.
68. Seeman E, Delmas PD. Bone quality - the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354(21):2250-61.
69. Hernandez CJ, Keaveny TM. A biomechanical perspective on bone quality. Bone. 2006;39(6):1173-81.
70. Bouxsein ML. Bone quality: where do we go from here? Osteoporos Int. 2003;14(Suppl 5):S118-27.
71. Allen MR, Burr D. Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone. Bonekey Osteovision. 2007;4:49-60.
72. Follet H, Boivin G, Rumelhart C, et al. The degree of mineralization is a determinant of bone strength: a study on human calcanei. Bone. 2004;34(5):783-9.
73. Loveridge N, Power J, Reeve J, et al. Bone mineralization density and femoral neck fragility. Bone. 2004;35(4):929-41.
74. Currey JD. Bone strength: what are we trying to measure? Calcif Tissue Int. 2001;68(4):205-10.
75. Boivin GY, Chavassieux PM, Santora AC, et al. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000;27(5):687-94.
76. Roschger P, Rinnerthaler S, Yates J, et al. Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone. 2001;29(2):185-91.
77. Boivin G, Meunier PJ. Changes in bone remodeling rate influence the degree of mineralization of bone. Connect Tissue Res. 2002;43(2-3):535-7.
78. Cranney A, Wells G, Willan A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev. 2002;23(4):508-16.
79. Arlot M, Meunier PJ, Boivin G, et al. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res. 2005;20(7):1244-53.
80. Finkelstein JS, Leder BZ, Burnett SM, et al. Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men. J Clin Endocrinol Metab. 2006;91(8):2882-7.
81. Misof BM, Roschger P, Cosman F, et al. Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab. 2003;88(3):1150-6.
82. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434-41.
83. Ascenzi MG, Liao VP, Lee BM, et al. Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis. J Bone Miner Res. 2012;27(3):702-12.
84. Fratzl P, Gupta H, Paschalis E, et al. Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem. 2004;14:2115-23.
85. Golub EE. Role of matrix vesicles in biomineralization. Biochim Biophys Acta. 2009;1790(12):1592-8.
86. Viguet-Carrin S, Garnero P, Delmas PD. The role of collagen in bone strength. Osteoporos Int. 2006;17(3):319-36.
87. Martin E, Shapiro JR. Osteogenesis imperfecta: epidemiology and pathophysiology. Curr Osteoporos Rep. 2007;5(3):91-7.
88. Simon JA, Hudes ES. Relation of ascorbic acid to bone mineral density and self-reported fractures among US adults. Am J Epidemiol. 2001;154(5):427-33.
89. Michaelsson K, Holmberg L, Mallmin H, et al. Diet and hip fracture risk: a case-control study. Study Group of the Multiple Risk Survey on Swedish Women for Eating Assessment. Int J Epidemiol. 1995;24(4):771-82.
90. Pinnell SR. Regulation of collagen biosynthesis by ascorbic acid: a review. Yale J Biol Med. 1985;58(6):553-9.
91. Oxlund H, Barckman M, Ortoft G, et al. Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone. 1995;17(4 Suppl):365S-71S.
92. Bailey AJ, Sims TJ, Ebbesen EN, et al. Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int. 1999;65(3):203-10.
93. Banse X, Sims TJ, Bailey AJ. Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res. 2002;17(9):1621-8.
94. Mochida Y, Parisuthiman D, Pornprasertsuk-Damrongsri S, et al. Decorin modulates collagen matrix assembly and mineralization. Matrix Biol. 2009;28(1):44-52.
95. Wallace JM, Golcuk K, Morris MD, et al. Inbred strain-specific response to biglycan deficiency in the cortical bone of C57BL6/129 and C3H/He mice. J Bone Miner Res. 2009;24(6):1002-12.
96. Martin RB, Ishida J. The relative effects of collagen fiber orientation, porosity, density, and mineralization on bone strength. J Biomech. 1989;22(5):419-26.
97. Silva MJ, Brodt MD, Wopenka B, et al. Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the SAMP6 mouse. J Bone Miner Res. 2006;21(1):78-88.
98. Kasper M, Funk RH. Age-related changes in cells and tissues due to advanced glycation end products (AGEs). Arch Gerontol Geriatr. 2001;32(3):233-43.
99. Garnero P, Borel O, Gineyts E, et al. Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone. 2006;38(3):300-9.
100. Saito M, Mori S, Mashiba T, et al. Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs. Osteoporos Int. 2008;19(9):1343-54.
101. Vashishth D, Gibson GJ, Khoury JI, et al. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone. 2001;28(2):195-201.
102. Wang X, Shen X, Li X, et al. Age-related changes in the collagen network and toughness of bone. Bone. 2002;31(1):1-7.
103. Hernandez CJ, Tang SY, Baumbach BM, et al. Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone. 2005;37(6):825-32.
104. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporos Int. 2007;18(4):427-44.
105. Saito M, Fujii K, Soshi S, et al. Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int. 2006;17(7):986-95.
106. Shiraki M, Kuroda T, Tanaka S, et al. Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab. 2008;26(1):93-100.
107. Giangregorio LM, Leslie WD, Lix LM, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. 2012;27(2):301-8.
108. Schwartz AV, Sellmeyer DE. Diabetes, fracture, and bone fragility. Curr Osteoporos Rep. 2007;5(3):105-11.
109. Bailey AJ, Wotton SF, Sims TJ, et al. Biochemical changes in the collagen of human osteoporotic bone matrix. Connect Tissue Res. 1993;29(2):119-32.
110. Kowitz J, Knippel M, Schuhr T, et al. Alteration in the extent of collagen I hydroxylation, isolated from femoral heads of women with a femoral neck fracture caused by osteoporosis. Calcif Tissue Int. 1997;60(6):501-5.
111. Paschalis EP, Shane E, Lyritis G, et al. Bone fragility and collagen cross-links. J Bone Miner Res. 2004;19(12):2000-4.
112. Isaksson H, Tolvanen V, Finnila MA, et al. Physical exercise improves properties of bone and its collagen network in growing and maturing mice. Calcif Tissue Int. 2009;85(3):247-56.
113. Wallace JM, Ron MS, Kohn DH. Short-term exercise in mice increases tibial post-yield mechanical properties while two weeks of latency following exercise increases tissue-level strength. Calcif Tissue Int. 2009;84(4):297-304.
114. Wallace JM, Rajachar RM, Allen MR, et al. Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific. Bone. 2007;40(4):1120-7.
115. Shiiba M, Arnaud SB, Tanzawa H, et al. Regional alterations of type I collagen in rat tibia induced by skeletal unloading. J Bone Miner Res. 2002;17(9):1639-45.
116. Brama PA, Bank RA, Tekoppele JM, et al. Training affects the collagen framework of subchondral bone in foals. Vet J. 2001;162(1):24-32.
117. Puustjarvi K, Nieminen J, Rasanen T, et al. Do more highly organized collagen fibrils increase bone mechanical strength in loss of mineral density after one-year running training? J Bone Miner Res. 1999;14(3):321-9.
118. Avery NC, Bailey AJ. Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise. Scand J Med Sci Sports. 2005;15(4):231-40.
119. Boivin G, Meunier PJ. Effects of bisphosphonates on matrix mineralization. J Musculoskelet Neuronal Interact. 2002;2(6):538-43.
120. Boivin G, Meunier PJ. The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography. Calcif Tissue Int. 2002;70(6):503-11.
121. Boivin G, Meunie PJ. Changes in bone remodeling rate influence the degree of mineralization of bone which is a determinant of bone strength: therapeutic implications. Adv Exp Med Biol. 2001;496:123-7.
122. Sornay-Rendu E, Munoz F, Duboeuf F, et al. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study. J Bone Miner Res. 2005;20(11):1929-35.
123. Bjarnason NH, Sarkar S, Duong T, et al. Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis. Osteoporos Int. 2001;12(11):922-30.
124. Sarkar S, Mitlak BH, Wong M, et al. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res. 2002;17(1):1-10.
125. Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008;358(12):1304-6.
126. Neviaser AS, Lane JM, Lenart BA, et al. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008;22(5):346-50.
127. Donnelly E, Meredith DS, Nguyen JT, et al. Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res. 2012;27(3):672-8.
128. Meunier PJ, Boivin G. Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications. Bone. 1997;21(5):373-7.
129. Currey JD. Physical characteristics affecting the tensile failure properties of compact bone. J Biomech. 1990;23(8):837-44.
130. Mashiba T, Hirano T, Turner CH, et al. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2000;15(4):613-20.
131. Mashiba T, Turner CH, Hirano T, et al. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone. 2001;28(5):524-31.
132. Burr DB, Turner CH, Naick P, et al. Does microdamage accumulation affect the mechanical properties of bone? J Biomech. 1998;31(4):337-45.
133. Odvina CV, Zerwekh JE, Rao DS, et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90(3):1294-301.
134. Boskey A. Bone mineral crystal size. Osteoporos Int. 2003;14 Suppl 5:S16-20 (discussion S-1).
135. Yerramshetty JS, Lind C, Akkus O. The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade. Bone. 2006;39(6):1236-43.
136. Delmas PD, Ensrud KE, Adachi JD, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2002;87(8):3609-17.
137. Boivin G, Lips P, Ott SM, et al. Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women. J Clin Endocrinol Metab. 2003;88(9):4199-205.
138. Fratzl P, Fratzl-Zelman N, Klaushofer K, et al. Nucleation and growth of mineral crystals in bone studied by small-angle X-ray scattering. Calcif Tissue Int. 1991;48(6):407-13.
139. Paschalis EP, Burr DB, Mendelsohn R, et al. Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months. J Bone Miner Res. 2003;18(4):769-75.
140. Khosla S, Atkinson EJ, Melton LJ 3rd, et al. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab. 1997;82(5):1522-7.
141. Yerramshetty JS, Akkus O. The associations between mineral crystallinity and the mechanical properties of human cortical bone. Bone. 2008;42(3):476-82.
142. Gajjeraman S, Narayanan K, Hao J, et al. Matrix macromolecules in hard tissues control the nucleation and hierarchical assembly of hydroxyapatite. J Biol Chem. 2007;282(2):1193-204.
143. Addadi L, Weiner S, Geva M. On how proteins interact with crystals and their effect on crystal formation. Z Kardiol. 2001;90(Suppl 3):92-8.
144. Veis A. Materials science. A window on biomineralization. Science. 2005;307(5714):1419-20.
145. Arnold S, Plate U, Wiesmann HP, et al. Quantitative analyses of the biomineralization of different hard tissues. J Microsc. 2001;202(Pt 3):488-94.
146. Addison WN, McKee MD. ASARM mineralization hypothesis: a bridge to progress. J Bone Miner Res. 2010;25(5):1191-2.
147. Addison WN, Masica DL, Gray JJ, et al. Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res. 2010;25(4):695-705.
148. Dickson IR, Bagga MK. Changes with age in the non-collagenous proteins of human bone. Connect Tissue Res. 1985;14(1):77-85.
149. Xie LQ, Jacobson JM, Choi ES, et al. Low-level mechanical vibrations can influence bone resorption and bone formation in the growing skeleton. Bone. 2006;39(5):1059-66.
150. Prioreschi A, Oosthuyse T, Avidon I, et al. Whole body vibration increases hip bone mineral density in road cyclists. Int J Sports Med. 2012;33(8):593-9.
151. Wang H, Wan Y, Tam KF, et al. Resistive vibration exercise retards bone loss in weight-bearing skeletons during 60 days bed rest. Osteoporos Int. 2012;23(8):2169-78.
152. Sehmisch S, Galal R, Kolios L, et al. Effects of low-magnitude, high-frequency mechanical stimulation in the rat osteopenia model. Osteoporos Int. 2009;20(12):1999-2008.
153. Hamilton CJ, Swan VJ, Jamal SA. The effects of exercise and physical activity participation on bone mass and geometry in postmenopausal women: a systematic review of pQCT studies. Osteoporos Int. 2010;21(1):11-23.
154. Huang TH, Lin SC, Chang FL, et al. Effects of different exercise modes on mineralization, structure, and biomechanical properties of growing bone. J Appl Physiol. 2003;95(1):300-7.
155. Nyman JS, Roy A, Shen X, et al. The influence of water removal on the strength and toughness of cortical bone. J Biomech. 2006;39(5):931-8.
156. Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011;26(2):229-38.
157. Kurata K, Heino TJ, Higaki H, et al. Bone marrow cell differentiation induced by mechanically damaged osteocytes in 3D gel-embedded culture. J Bone Miner Res. 2006;21(4):616-25.
158. Eberhardt AW, Yeager-Jones A, Blair HC. Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid-treated rabbits. Endocrinology. 2001;142(3):1333-40.
159. Heino TJ, Hentunen TA, Vaananen HK. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem. 2002;85(1):185-97.
160. Zhao S, Zhang YK, Harris S, et al. MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J Bone Miner Res. 2002;17(11):2068-79.
161. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-42.
162. Kogianni G, Mann V, Noble BS. Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res. 2008;23(6):915-27.
163. Cardoso L, Herman BC, Verborgt O, et al. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res. 2009;24(4):597-605.
164. Gu G, Mulari M, Peng Z, et al. Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption. Biochem Biophys Res Commun. 2005;335(4):1095-101.
165. Tatsumi S, Ishii K, Amizuka N, et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007;5(6):464-75.
166. Dunstan CR, Somers NM, Evans RA. Osteocyte death and hip fracture. Calcif Tissue Int. 1993;53 Suppl 1:S113-6 (discussion S6-7).
167. Liu C, Zhao Y, Cheung WY, et al. Effects of cyclic hydraulic pressure on osteocytes. Bone. 2010;46(5):1449-56.
168. Bonivtch AR, Bonewald LF, Nicolella DP. Tissue strain amplification at the osteocyte lacuna: a microstructural finite element analysis. J Biomech. 2007;40(10):2199-206.
169. Vatsa A, Mizuno D, Smit TH, et al. Bio imaging of intracellular NO production in single bone cells after mechanical stimulation. J Bone Miner Res. 2006;21(11):1722-8.
170. Ajubi NE, Klein-Nulend J, Alblas MJ, et al. Signal transduction pathways involved in fluid flow-induced PGE2 production by cultured osteocytes. Am J Physiol. 1999;276(1 Pt 1):E171-8.
171. Bakker AD, Soejima K, Klein-Nulend J, et al. The production of nitric oxide and prostaglandin E(2) by primary bone cells is shear stress dependent. J Biomech. 2001;34(5):671-7.
172. Poole KE, van Bezooijen RL, Loveridge N, et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 2005;19(13):1842-4.
173. Klein-Nulend J, Bakker AD, Bacabac RG, et al. Mechanosensation and transduction in osteocytes. Bone. 2013;54(2):182-90.
174. Imai S, Heino TJ, Hienola A, et al. Osteocyte-derived HB-GAM (pleiotrophin) is associated with bone formation and mechanical loading. Bone. 2009;44(5):785-94.
175. Fox SW, Chambers TJ, Chow JW. Nitric oxide is an early mediator of the increase in bone formation by mechanical stimulation. Am J Physiol. 1996;270(6 Pt 1):E955-60.
176. Turner CH, Takano Y, Owan I, et al. Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. Am J Physiol. 1996;270(4 Pt 1):E634-9.
177. Cherian PP, Siller-Jackson AJ, Gu S, et al. Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell. 2005;16(7):3100-6.
178. Yoshida K, Oida H, Kobayashi T, et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci USA. 2002;99(7):4580-5.
179. Keila S, Kelner A, Weinreb M. Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro. J Endocrinol. 2001;168(1):131-9.
180. Robling AG, Niziolek PJ, Baldridge LA, et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2008;283(9):5866-75.
181. Galli C, Passeri G, Macaluso GM. Osteocytes and WNT: the mechanical control of bone formation. J Dent Res. 2010;89(4):331-43.
182. Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell and more. Endocr Rev. Epub 2013 Apr 26.
183. Gowen LC, Petersen DN, Mansolf AL, et al. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem. 2003;278(3):1998-2007.
184. Kulkarni RN, Bakker AD, Everts V, et al. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE. Calcif Tissue Int. 2010;87(5):461-8.
185. Toyosawa S, Shintani S, Fujiwara T, et al. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res. 2001;16(11):2017-26.
186. Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006;38(11):1310-5.
187. Gluhak-Heinrich J, Ye L, Bonewald LF, et al. Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res. 2003;18(5):807-17.
188. Qiu S, Rao DS, Palnitkar S, et al. Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture. J Bone Miner Res. 2003;18(9):1657-63.
189. Vashishth D, Verborgt O, Divine G, et al. Decline in osteocyte lacunar density in human cortical bone is associated with accumulation of microcracks with age. Bone. 2000;26(4):375-80.
190. Emerton KB, Hu B, Woo AA, et al. Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone. 2009;46(3):577-83.
191. O'Brien CA, Jia D, Plotkin LI, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 2004;145(4):1835-41.
192. Plotkin LI, Manolagas SC, Bellido T. Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis. J Biol Chem. 2007;282(33):24120-30.
193. Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab. 2000;85(8):2907-12.
194. Sampson HW, Hebert VA, Booe HL, et al. Effect of alcohol consumption on adult and aged bone: composition, morphology, and hormone levels of a rat animal model. Alcohol Clin Exp Res. 1998;22(8):1746-53.
195. Turner RT, Kidder LS, Kennedy A, et al. Moderate alcohol consumption suppresses bone turnover in adult female rats. J Bone Miner Res. 2001;16(3):589-94.
196. Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int. 2005;16(7):737-42.
197. Maurel DB, Jaffre C, Rochefort GY, et al. Low bone accrual is associated with osteocyte apoptosis in alcohol-induced osteopenia. Bone. 2011;49(3):543-52.
198. Fonseca H, Moreira-Goncalves D, Esteves JL, et al. Voluntary exercise has long-term in vivo protective effects on osteocyte viability and bone strength following ovariectomy. Calcif Tissue Int. 2011;88(6):443-54.
199. Miserez A, Schneberk T, Sun C, et al. The transition from stiff to compliant materials in squid beaks. Science. 2008;319(5871):1816-9.
200. Wilson EE, Awonusi A, Morris MD, et al. Three structural roles for water in bone observed by solid-state NMR. Biophys J. 2006;90(10):3722-31.
201. You LD, Weinbaum S, Cowin SC, et al. Ultrastructure of the osteocyte process and its pericellular matrix. Anat Rec A Discov Mol Cell Evol Biol. 2004;278(2):505-13.
202. Weinstein RS, Wan C, Liu Q, et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell. 2010;9(2):147-61.
203. Ishijima H, Ishizaka H, Horikoshi H, et al. Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex. AJR Am J Roentgenol. 1996;167(2):355-8.
204. Liebschner MA, Keller TS. Hydraulic strengthening affects the stiffness and strength of cortical bone. Ann Biomed Eng. 2005;33(1):26-38.
205. Busse B, Djonic D, Milovanovic P, et al. Decrease in the osteocyte lacunar density accompanied by hypermineralized lacunar occlusion reveals failure and delay of remodeling in aged human bone. Aging Cell. 2010;9(6):1065-75.
206. Frost HM. Micropetrosis. J Bone Joint Surg. 1960;42-A:144-50.
207. Aguirre JI, Plotkin LI, Stewart SA, et al. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res. 2006;21(4):605-15.
208. Dodd JS, Raleigh JA, Gross TS. Osteocyte hypoxia: a novel mechanotransduction pathway. Am J Physiol. 1999;277(3 Pt 1):C598-602.
209. Noble BS, Peet N, Stevens HY, et al. Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol. 2003;284(4):C934-43.
210. Bakker A, Klein-Nulend J, Burger E. Shear stress inhibits while disuse promotes osteocyte apoptosis. Biochem Biophys Res Commun. 2004;320(4):1163-8.
211. Plotkin LI, Mathov I, Aguirre JI, et al. Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Am J Physiol Cell Physiol. 2005;289(3):C633-43.
212. Kitase Y, Barragan L, Qing H, et al. Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the beta-catenin and PKA pathways. J Bone Miner Res. 2010;25(12):2657-68.
213. Fonseca H, Goncalves D, Figueiredo P, et al. Lifelong sedentary behaviour and femur structure. Int J Sports Med. 2011;32(5):344-52.
214. Mann V, Huber C, Kogianni G, et al. The influence of mechanical stimulation on osteocyte apoptosis and bone viability in human trabecular bone. J Musculoskelet Neuronal Interact. 2006;6(4):408-17.
215. Kulkarni RN, Bakker AD, Everts V, et al. Mechanical loading prevents the stimulating effect of IL-1beta on osteocyte-modulated osteoclastogenesis. Biochem Biophys Res Commun. 2012;420(1):11-6.
216. Siu WS, Qin L, Cheung WH, et al. A study of trabecular bones in ovariectomized goats with micro-computed tomography and peripheral quantitative computed tomography. Bone. 2004;35(1):21-6.
217. Laib A, Kumer JL, Majumdar S, et al. The temporal changes of trabecular architecture in ovariectomized rats assessed by MicroCT. Osteoporos Int. 2001;12(11):936-41.
218. Boyd SK, Davison P, Muller R, et al. Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography. Bone. 2006;39(4):854-62.
219. Turner CH. Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int. 2002;13(2):97-104.
220. Ikeda S, Tsurukami H, Ito M, et al. Effect of trabecular bone contour on ultimate strength of lumbar vertebra after bilateral ovariectomy in rats. Bone. 2001;28(6):625-33.
221. Fields AJ, Eswaran SK, Jekir MG, et al. Role of trabecular microarchitecture in whole-vertebral body biomechanical behavior. J Bone Miner Res. 2009;24(9):1523-30.
222. Khosla S, Riggs BL, Atkinson EJ, et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res. 2006;21(1):124-31.
223. Thomas CD, Mayhew PM, Power J, et al. Femoral neck trabecular bone: loss with aging and role in preventing fracture. J Bone Miner Res. 2009;24(11):1808-18.
224. Borah B, Dufresne TE, Chmielewski PA, et al. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J Bone Miner Res. 2002;17(7):1139-47.
225. Wehrli FW, Rajapakse CS, Magland JF, et al. Mechanical implications of estrogen supplementation in early postmenopausal women. J Bone Miner Res. 2010;25(6):1406-14.
226. Chappard D, Legrand E, Basle MF, et al. Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res. 1996;11(5):676-85.
227. Legrand E, Chappard D, Pascaretti C, et al. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res. 2000;15(1):13-9.
228. Sran MM, Boyd SK, Cooper DM, et al. Regional trabecular morphology assessed by micro-CT is correlated with failure of aged thoracic vertebrae under a posteroanterior load and may determine the site of fracture. Bone. 2007;40(3):751-7.
229. Sran MM, Khan KM, Zhu Q, et al. Failure characteristics of the thoracic spine with a posteroanterior load: investigating the safety of spinal mobilization. Spine (Phila Pa 1976). 2004;29(21):2382-8.
230. MacNeil JA, Boyd SK. Load distribution and the predictive power of morphological indices in the distal radius and tibia by high resolution peripheral quantitative computed tomography. Bone. 2007;41(1):129-37.
231. Bell KL, Loveridge N, Power J, et al. Regional differences in cortical porosity in the fractured femoral neck. Bone. 1999;24(1):57-64.
232. Holzer G, von Skrbensky G, Holzer LA, et al. Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res. 2009;24(3):468-74.
233. Burghardt AJ, Kazakia GJ, Ramachandran S, et al. Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res. 2010;25(5):983-93.
234. Cooper DM, Thomas CD, Clement JG, et al. Age-dependent change in the 3D structure of cortical porosity at the human femoral midshaft. Bone. 2007;40(4):957-65.
235. Sietsema WK. Animal models of cortical porosity. Bone. 1995;17(4 Suppl):297S-305S.
236. Nicks KM, Amin S, Atkinson EJ, et al. Relationship of age to bone microstructure independent of areal bone mineral density. J Bone Miner Res. 2012;27(3):637-44.
237. Dong XN, Guo XE. The dependence of transversely isotropic elasticity of human femoral cortical bone on porosity. J Biomech. 2004;37(8):1281-7.
238. Rianon NJ, Lang TF, Sigurdsson G, et al. Lifelong physical activity in maintaining bone strength in older men and women of the Age, Gene/Environment Susceptibility-Reykjavik Study. Osteoporos Int. 2012;23(9):2303-12.
239. Uusi-Rasi K, Sievanen H, Pasanen M, et al. Associations of calcium intake and physical activity with bone density and size in premenopausal and postmenopausal women: a peripheral quantitative computed tomography study. J Bone Miner Res. 2002;17(3):544-52.
240. Sugiyama T, Price JS, Lanyon LE. Functional adaptation to mechanical loading in both cortical and cancellous bone is controlled locally and is confined to the loaded bones. Bone. 2010;46(2):314-21.
241. Fritton JC, Myers ER, Wright TM, et al. Bone mass is preserved and cancellous architecture altered due to cyclic loading of the mouse tibia after orchidectomy. J Bone Miner Res. 2008;23(5):663-71.
242. Lynch ME, Main RP, Xu Q, et al. Cancellous bone adaptation to tibial compression is not sex dependent in growing mice. J Appl Physiol. 2010;109(3):685-91.
243. Joo YI, Sone T, Fukunaga M, et al. Effects of endurance exercise on three-dimensional trabecular bone microarchitecture in young growing rats. Bone. 2003;33(4):485-93.
244. Iwamoto J, Yeh JK, Aloia JF. Differential effect of treadmill exercise on three cancellous bone sites in the young growing rat. Bone. 1999;24(3):163-9.
245. Notomi T, Okimoto N, Okazaki Y, et al. Effects of tower climbing exercise on bone mass, strength, and turnover in growing rats. J Bone Miner Res. 2001;16(1):166-74.
246. Notomi T, Okazaki Y, Okimoto N, et al. Effects of tower climbing exercise on bone mass, strength, and turnover in orchidectomized growing rats. J Appl Physiol. 2002;93(3):1152-8.
247. Gross TS, Rubin CT. Uniformity of resorptive bone loss induced by disuse. J Orthop Res. 1995;13(5):708-14.
248. Fonseca H, Moreira-Goncalves D, Vaz M, et al. Changes in proximal femur bone properties following ovariectomy and their association with resistance to fracture. J Bone Miner Metab. 2012;30(3):281-92.
249. Alele JD, Kamen DL, Hunt KJ, et al. Bone geometry profiles in women with and without SLE. J Bone Miner Res. 2011;26(11):2719-26.
250. Taes Y, Lapauw B, Griet V, et al. Prevalent fractures are related to cortical bone geometry in young healthy men at age of peak bone mass. J Bone Miner Res. 2010;25(6):1433-40.
251. Ammann P, Rizzoli R, Meyer JM, et al. Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats. Osteoporos Int. 1996;6(3):219-27.
252. Ejersted C, Andreassen TT, Oxlund H, et al. Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res. 1993;8(9):1097-101.
253. Andreassen TT, Jorgensen PH, Flyvbjerg A, et al. Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res. 1995;10(7):1057-67.
254. Nelson DA, Pettifor JM, Barondess DA, et al. Comparison of cross-sectional geometry of the proximal femur in white and black women from Detroit and Johannesburg. J Bone Miner Res. 2004;19(4):560-5.
255. Nelson DA, Barondess DA, Hendrix SL, et al. Cross-sectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women. J Bone Miner Res. 2000;15(10):1992-7.
256. Russo CR, Lauretani F, Bandinelli S, et al. Aging bone in men and women: beyond changes in bone mineral density. Osteoporos Int. 2003;14(7):531-8.
257. Russo CR, Lauretani F, Seeman E, et al. Structural adaptations to bone loss in aging men and women. Bone. 2006;38(1):112-8.
258. Seeman E. Periosteal bone formation-a neglected determinant of bone strength. N Engl J Med. 2003;349(4):320-3.
259. Orwoll ES. Toward an expanded understanding of the role of the periosteum in skeletal health. J Bone Miner Res. 2003;18(6):949-54.
260. Nakamura T, Turner CH, Yoshikawa T, et al. Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans? J Bone Miner Res. 1994;9(7):1071-6.
261. Faulkner KG, Wacker WK, Barden HS, et al. Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int. 2006;17(4):593-9.
262. Siu WS, Qin L, Leung KS. pQCT bone strength index may serve as a better predictor than bone mineral density for long bone breaking strength. J Bone Miner Metab. 2003;21(5):316-22.
263. Beck TJ. Extending DXA beyond bone mineral density: understanding hip structure analysis. Curr Osteoporos Rep. 2007;5(2):49-55.
264. Pulkkinen P, Partanen J, Jalovaara P, et al. Combination of bone mineral density and upper femur geometry improves the prediction of hip fracture. Osteoporos Int. 2004;15(4):274-80.
265. El-Kaissi S, Pasco JA, Henry MJ, et al. Femoral neck geometry and hip fracture risk: the Geelong osteoporosis study. Osteoporos Int. 2005;16(10):1299-303.
266. Frisoli A Jr, Paula AP, Pinheiro M, et al. Hip axis length as an independent risk factor for hip fracture independently of femural bone mineral density in Caucasian elderly Brazilian women. Bone. 2005;37(6):871-5.
267. Bergot C, Bousson V, Meunier A, et al. Hip fracture risk and proximal femur geometry from DXA scans. Osteoporos Int. 2002;13(7):542-50.
268. Theobald TM, Cauley JA, Gluer CC, et al. Black-white differences in hip geometry. Study of Osteoporotic Fractures Research Group. Osteoporos Int. 1998;8(1):61-7.
269. Michelotti J, Clark J. Femoral neck length and hip fracture risk. J Bone Miner Res. 1999;14(10):1714-20.
270. Alonso CG, Curiel MD, Carranza FH, et al. Femoral bone mineral density, neck-shaft angle and mean femoral neck width as predictors of hip fracture in men and women. Multicenter Project for Research in Osteoporosis. Osteoporos Int. 2000;11(8):714-20.
271. Faulkner KG, Cummings SR, Black D, et al. Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res. 1993;8(10):1211-7.
272. Parkkari J, Kannus P, Palvanen M, et al. Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int. 1999;65(3):183-7.
273. Wang Q, Teo JW, Ghasem-Zadeh A, et al. Women and men with hip fractures have a longer femoral neck moment arm and greater impact load in a sideways fall. Osteoporos Int. 2009;20(7):1151-6.
274. Cheung CL, Livshits G, Zhou Y, et al. Hip geometry variation is associated with bone mineralization pathway gene variants: The Framingham Study. J Bone Miner Res. 2010;25(7):1564-71.
275. Greenspan SL, Beck TJ, Resnick NM, et al. Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial. J Bone Miner Res. 2005;20(9):1525-32.
276. Uusi-Rasi K, Semanick LM, Zanchetta JR, et al. Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone. 2005;36(6):948-58.
277. Korhonen MT, Heinonen A, Siekkinen J, et al. Bone density, structure and strength and their determinants in aging sprint athletes. Med Sci Sports Exerc. 2012;44:2340-9.
278. Nikander R, Kannus P, Dastidar P, et al. Targeted exercises against hip fragility. Osteoporos Int. 2009;20(8):1321-8.
279. Duncan CS, Blimkie CJ, Kemp A, et al. Mid-femur geometry and biomechanical properties in 15- to 18-yr-old female athletes. Med Sci Sports Exerc. 2002;34(4):673-81.
280. Farr JN, Blew RM, Lee VR, et al. Associations of physical activity duration, frequency, and load with volumetric BMD, geometry, and bone strength in young girls. Osteoporos Int. 2011;22(5):1419-30.
281. Petit MA, McKay HA, MacKelvie KJ, et al. A randomized school-based jumping intervention confers site and maturity-specific benefits on bone structural properties in girls: a hip structural analysis study. J Bone Miner Res. 2002;17(3):363-72.
282. Karinkanta S, Heinonen A, Sievanen H, et al. A multi-component exercise regimen to prevent functional decline and bone fragility in home-dwelling elderly women: randomized, controlled trial. Osteoporos Int. 2007;18(4):453-62.
283. Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010;31:266-300.
284. Saito M, Fujii K, Mori Y, et al. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int. 2006;17(10):1514-23.